Cargando…

Non-oral manifestations in adults with a clinical and molecularly confirmed diagnosis of periodontal Ehlers-Danlos syndrome

Introduction: Periodontal Ehlers-Danlos Syndrome (pEDS) is a rare autosomal dominant type of EDS characterised by severe early-onset periodontitis, lack of attached gingiva, pretibial plaques, joint hypermobility and skin hyperextensibility as per the 2017 International EDS Classification. In 2016,...

Descripción completa

Detalles Bibliográficos
Autores principales: Angwin, C., Zschocke, J., Kammin, T., Björck, E., Bowen, J., Brady, A. F., Burns, H., Cummings, C., Gardner, R., Ghali, N., Gröbner, R., Harris, J., Higgins, M., Johnson, D., Lepperdinger, U., Milnes, D., Pope, F. M., Sehra, R., Kapferer-Seebacher, I., Sobey, G., Van Dijk, F. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264792/
https://www.ncbi.nlm.nih.gov/pubmed/37323685
http://dx.doi.org/10.3389/fgene.2023.1136339
_version_ 1785058402148286464
author Angwin, C.
Zschocke, J.
Kammin, T.
Björck, E.
Bowen, J.
Brady, A. F.
Burns, H.
Cummings, C.
Gardner, R.
Ghali, N.
Gröbner, R.
Harris, J.
Higgins, M.
Johnson, D.
Lepperdinger, U.
Milnes, D.
Pope, F. M.
Sehra, R.
Kapferer-Seebacher, I.
Sobey, G.
Van Dijk, F. S.
author_facet Angwin, C.
Zschocke, J.
Kammin, T.
Björck, E.
Bowen, J.
Brady, A. F.
Burns, H.
Cummings, C.
Gardner, R.
Ghali, N.
Gröbner, R.
Harris, J.
Higgins, M.
Johnson, D.
Lepperdinger, U.
Milnes, D.
Pope, F. M.
Sehra, R.
Kapferer-Seebacher, I.
Sobey, G.
Van Dijk, F. S.
author_sort Angwin, C.
collection PubMed
description Introduction: Periodontal Ehlers-Danlos Syndrome (pEDS) is a rare autosomal dominant type of EDS characterised by severe early-onset periodontitis, lack of attached gingiva, pretibial plaques, joint hypermobility and skin hyperextensibility as per the 2017 International EDS Classification. In 2016, deleterious pathogenic heterozygous variants were identified in C1R and C1S, which encode components of the complement system. Materials and Methods: Individuals with a clinical suspicion of pEDS were clinically and molecularly assessed through the National EDS Service in London and Sheffield and in genetic services in Austria, Sweden and Australia. Transmission electron microscopy and fibroblast studies were performed in a small subset of patients. Results: A total of 21 adults from 12 families were clinically and molecularly diagnosed with pEDS, with C1R variants in all families. The age at molecular diagnosis ranged from 21–73 years (mean 45 years), male: female ratio 5:16. Features of easy bruising (90%), pretibial plaques (81%), skin fragility (71%), joint hypermobility (24%) and vocal changes (38%) were identified as well as leukodystrophy in 89% of those imaged. Discussion: This cohort highlights the clinical features of pEDS in adults and contributes several important additional clinical features as well as novel deleterious variants to current knowledge. Hypothetical pathogenic mechanisms which may help to progress understanding and management of pEDS are also discussed.
format Online
Article
Text
id pubmed-10264792
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102647922023-06-15 Non-oral manifestations in adults with a clinical and molecularly confirmed diagnosis of periodontal Ehlers-Danlos syndrome Angwin, C. Zschocke, J. Kammin, T. Björck, E. Bowen, J. Brady, A. F. Burns, H. Cummings, C. Gardner, R. Ghali, N. Gröbner, R. Harris, J. Higgins, M. Johnson, D. Lepperdinger, U. Milnes, D. Pope, F. M. Sehra, R. Kapferer-Seebacher, I. Sobey, G. Van Dijk, F. S. Front Genet Genetics Introduction: Periodontal Ehlers-Danlos Syndrome (pEDS) is a rare autosomal dominant type of EDS characterised by severe early-onset periodontitis, lack of attached gingiva, pretibial plaques, joint hypermobility and skin hyperextensibility as per the 2017 International EDS Classification. In 2016, deleterious pathogenic heterozygous variants were identified in C1R and C1S, which encode components of the complement system. Materials and Methods: Individuals with a clinical suspicion of pEDS were clinically and molecularly assessed through the National EDS Service in London and Sheffield and in genetic services in Austria, Sweden and Australia. Transmission electron microscopy and fibroblast studies were performed in a small subset of patients. Results: A total of 21 adults from 12 families were clinically and molecularly diagnosed with pEDS, with C1R variants in all families. The age at molecular diagnosis ranged from 21–73 years (mean 45 years), male: female ratio 5:16. Features of easy bruising (90%), pretibial plaques (81%), skin fragility (71%), joint hypermobility (24%) and vocal changes (38%) were identified as well as leukodystrophy in 89% of those imaged. Discussion: This cohort highlights the clinical features of pEDS in adults and contributes several important additional clinical features as well as novel deleterious variants to current knowledge. Hypothetical pathogenic mechanisms which may help to progress understanding and management of pEDS are also discussed. Frontiers Media S.A. 2023-05-31 /pmc/articles/PMC10264792/ /pubmed/37323685 http://dx.doi.org/10.3389/fgene.2023.1136339 Text en Copyright © 2023 Angwin, Zschocke, Kammin, Björck, Bowen, Brady, Burns, Cummings, Gardner, Ghali, Gröbner, Harris, Higgins, Johnson, Lepperdinger, Milnes, Pope, Sehra, Kapferer-Seebacher, Sobey and Van Dijk. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Angwin, C.
Zschocke, J.
Kammin, T.
Björck, E.
Bowen, J.
Brady, A. F.
Burns, H.
Cummings, C.
Gardner, R.
Ghali, N.
Gröbner, R.
Harris, J.
Higgins, M.
Johnson, D.
Lepperdinger, U.
Milnes, D.
Pope, F. M.
Sehra, R.
Kapferer-Seebacher, I.
Sobey, G.
Van Dijk, F. S.
Non-oral manifestations in adults with a clinical and molecularly confirmed diagnosis of periodontal Ehlers-Danlos syndrome
title Non-oral manifestations in adults with a clinical and molecularly confirmed diagnosis of periodontal Ehlers-Danlos syndrome
title_full Non-oral manifestations in adults with a clinical and molecularly confirmed diagnosis of periodontal Ehlers-Danlos syndrome
title_fullStr Non-oral manifestations in adults with a clinical and molecularly confirmed diagnosis of periodontal Ehlers-Danlos syndrome
title_full_unstemmed Non-oral manifestations in adults with a clinical and molecularly confirmed diagnosis of periodontal Ehlers-Danlos syndrome
title_short Non-oral manifestations in adults with a clinical and molecularly confirmed diagnosis of periodontal Ehlers-Danlos syndrome
title_sort non-oral manifestations in adults with a clinical and molecularly confirmed diagnosis of periodontal ehlers-danlos syndrome
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264792/
https://www.ncbi.nlm.nih.gov/pubmed/37323685
http://dx.doi.org/10.3389/fgene.2023.1136339
work_keys_str_mv AT angwinc nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT zschockej nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT kammint nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT bjorcke nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT bowenj nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT bradyaf nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT burnsh nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT cummingsc nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT gardnerr nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT ghalin nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT grobnerr nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT harrisj nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT higginsm nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT johnsond nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT lepperdingeru nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT milnesd nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT popefm nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT sehrar nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT kapfererseebacheri nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT sobeyg nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome
AT vandijkfs nonoralmanifestationsinadultswithaclinicalandmolecularlyconfirmeddiagnosisofperiodontalehlersdanlossyndrome